Kirchhof Nicole
1 Medtronic PLC, Physiological Research Laboratories, Minneapolis, Minnesota, USA.
Toxicol Pathol. 2019 Apr;47(3):205-212. doi: 10.1177/0192623319827502. Epub 2019 Feb 5.
Medical device pathologists are involved in the preclinical evaluation of medical devices that will be temporarily inserted or permanently and often irreversibly implanted in the human body. The medical device industry is technology based, allowing for rapid device iterations; innovations occur at an accelerated rate compared to the innovations in the pharmaceutical industry. The device pathologist provides the pathology results and is, by training and experience, in an ideal position to help the medical engineer and innovator tackle biomedical problems and to comment on the possible and actual outcomes of preclinical studies. Device pathology expertise is typically a necessity in the prelude for regulatory submission. However, there is a lack of detailed guidelines for a comprehensive preclinical pathology evaluation of the final product after implantation in a test animal. What specifically unites device pathologists is the reliance on gross pathology as the basis for spatial context needed for appropriate histopathologic analyses, the knowledge of detailed protocol instructions, a good understanding of wound healing including the "implant trauma," and interaction with ambitious device innovators. In this article, it is my aim to amalgamate the following articles in this issue with pertinent background information intended to be informative, critical, and stimulating.
医疗器械病理学家参与对将临时插入或永久且通常不可逆地植入人体的医疗器械的临床前评估。医疗器械行业以技术为基础,允许设备快速迭代;与制药行业的创新相比,创新速度更快。器械病理学家提供病理结果,并且凭借培训和经验,处于帮助医学工程师和创新者解决生物医学问题以及对临床前研究的可能和实际结果发表评论的理想位置。器械病理学专业知识通常是监管申报前奏中的必要条件。然而,对于在实验动物体内植入最终产品后的全面临床前病理评估,缺乏详细的指导方针。器械病理学家的特别共同点在于依赖大体病理学作为进行适当组织病理学分析所需空间背景的基础、对详细方案说明有所了解、对包括“植入创伤”在内的伤口愈合有良好理解,以及与有抱负的器械创新者进行互动。在本文中,我的目的是将本期的以下文章与相关背景信息合并在一起,这些信息旨在提供信息、具有批判性且能激发思考。